Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Dementia with Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Dementia with Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dementia with Diabetes market report provides current ... Read More
-
Diabetes Insipidus – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetes Insipidus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetes Insipidus market report provides current treatment practices, emerging drugs, Diabetes ... Read More
-
Prediabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Prediabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Prediabetes market report provides current treatment practices, emerging drugs, Prediabetes market share of the individual ... Read More
-
Diabetic Gastroparesis (DGp) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Gastroparesis (DGp) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Gastroparesis (DGp) market report provides current ... Read More
-
Diabetic Neuropathic Pain – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Neuropathic Pain market report provides current ... Read More
-
Global Self-Monitoring Blood Glucose Device Market Report by Product (Test Strips, Lancets, Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), End-User (Hospital Pharmacies, Retail Pharmacies, Online Sales, and Diabetes Clinics & Centers), Regions and Company Analysis 2024-2032
... Centers), Regions and Company Analysis 2024-2032 The Self-Monitoring Blood Glucose Device Market will be US$ 21.05 billion by 2032 from US$ 11.68 Billion in 2023, with a CAGR of 6.76% during 2024 to 2032. Self-monitoring ... Read More
-
Diabetic Nephropathy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetic Nephropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Nephropathy market report provides current treatment practices, emerging drugs, Diabetic ... Read More
-
Diabetic Ketoacidosis (DKA) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Ketoacidosis (DKA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Ketoacidosis (DKA) market report provides current ... Read More
-
Diabetic Eye Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Eye Disease market report provides current ... Read More
-
Chronic Pain Associated with Painful Diabetic Neuropathy – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Chronic Pain Associated with Painful Diabetic Neuropathy, historical and forecasted epidemiology as well as the Chronic Pain Associated with Painful Diabetic Neuropathy market trends in the United States, EU5 (Germany, ... Read More
-
Diabetic Foot – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetic Foot market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Foot market report provides current treatment practices, emerging drugs, Diabetic ... Read More
-
Global Human Microbiome Market Report by Application (Therapeutics, Diagnostics) Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Other Diseases) Product (Probiotics, Prebiotics, Symboitics, Other Products), Countries and Company Analysis, 2024-2032
... Human Microbiome Market will grow US$ 3.05 Billion by 2032 from US$ 0.72 Billion in 2023, with a CAGR of 17.48% during 2023-2032. The human microbiome is a collection of microorganisms found on and within ... Read More
-
Global Continuous Glucose Monitoring Market Report by Component (Sensors, Transmitters, Receivers), End-User (Hospitals, Homecare Settings, Others), Regions and Company Analysis 2024-2032
... to reach US$ 13.06 Billion by 2032, with a Compound Annual Growth Rate of 8.40% from 2024 to 2032. Continuous glucose monitoring is an effective tool that mechanically estimates blood glucose levels at day and ... Read More
-
Global Insulin Pen Market Report by Product (Disposable Insulin Pen and Reusable Insulin Pen), Disease types (Type 1 Diabetes and Type 2 Diabetes), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and E-commerce) Regions and Company Analysis 2024-2032
... 2024-2032 The global insulin pen market will be US$ 10.71 billion by 2032 from US$ 6.27 billion in 2023, with a CAGR of 6.13% from 2024 to 2032. Insulin pens are the ultimate solution for ... Read More
-
Type 2 Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Type 2 Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Type 2 Diabetes market report provides current ... Read More
-
Gestational Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Gestational Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gestational Diabetes market report provides current treatment practices, emerging drugs, Gestational ... Read More
-
Diabetic Neuropathic Pain- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Insulin Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Diabetes Care Devices, Forecast to 2028
... is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, ... Read More
-
Diabetic Foot Ulcers - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Diabetic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Global Endocrinology Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 140400 million by 2030 with a CAGR of 5.0% during review period. Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and ... Read More
-
HbA1c Testing Market, By Type (Laboratory-based Testing, Point-of-Care Testing), Technology (Immunoassays, Chromatography, Boronate Affinity Chromatography, HPLC), End-use (Hospital, Diagnostic Labs, Homecare) –Forecast (2024 – 2032)
... during 2024-2032, driven by the rising prevalence of diabetes. According to Internation Diabetes Federation, in 2021, 537 million adults, or approximately 1 in 10, were living with diabetes. This number is projected to increase significantly, ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Global Hyper Personalized Medicine Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product (Medicine Diagnostics, Medicine Therapeutics, Medical Care, Nutrition and Wellness and Other Product Types), Application, End-User, Region, By Country: 2020-2030
... A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Hyper Personalized Medicine Market (2024 Edition)”. According to the report, Global Hyper Personalized Medicine Market registered market value of around ... Read More
-
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis
... forecast model for the Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity market through 2033. The use of GLP-1R agonists is expected to quadruple in the next 10 years, at a ... Read More
Research Assistance
